1. A117 SQUAMOUS CELL CARCINOMA (SCC) IN A PATIENT WITH FISTULIZING CROHN'S DISEASE (CD): AN UNUSUAL CAUSE FOR HYPERCALCEMIA. (1st March 2018) Authors: Rai, M; Al Ghamdi, S; Erin, K; Kenneth, C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-062 Effectiveness and safety of vedolizumab (vdz) in ibd patients: a multicentre experience of 'real world data' from the uk. (17th June 2017) Authors: Lenti, MV; Levison, S; Eliadou, E; Willert, R Robert; Kemp, K; Stansfield, C; Assadsangabi, A; Singh, S; Crooks, B; Tattersall, S; Kenneth, C; Subramanian, S; Probert, C; Storey, D; Gregg, B; Smith, P; Liu, E; Limdi, JK; Johnston, A; Hamlin, PJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P352 A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. (27th May 2021) Authors: Lenti, M V; Dolby, V; Clark, T; Hall, V; Tattersall, S; Fairhurst, F; Kenneth, C; Walker, R; Kemp, K; Borg-Bartolo, S; Limdi, J; Taylor, J; Townsend, T; Subramanian, S; Storey, D; Assadsangabi, A; Stansfield, C; Smith, P; Byrne, D; De Silvestri, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗